Martina Speight, NP
Nurse Practitioner · Stanford, CANPI 1881037984
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $129,669 of the $170,241 with a category attached, or 76.2%. Edwards Lifesciences accounts for 95.8% of it on its own, with 3 other manufacturers making up the rest. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $530.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$163K
- Medtronic$7K
- Cardiva Medical, Inc.$45
- Philips North America LLC$13
What the payments were for
- Consulting fees$129,66976%
- Speaking & faculty fees$5,3633%
- Travel & lodging$25,42915%
- Food & beverage$9,7786%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 299 | $163,168 |
| Medtronic | 20 | $7,016 |
| Cardiva Medical, Inc. | 1 | $45 |
| Philips North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$170,241 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $23,068 |
| Warfarin Sodium | 13 | $217 |
| Amlodipine Besylate | 12 | $127 |
| Furosemide | 15 | $102 |
| Metoprolol Tartrate | 16 | $80 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Stanford
- Rhonda HewittStanford$917K
- Hamta ZareStanford$428K
- Theresa Mallick-SearleStanford$193K
- Helen ShihStanford$104K
- Connie WolfordStanford$69K
- Michelle GapayStanford$37K
- Elaine JangStanford$32K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.